Stock Market News — November 02, 2026 — Morning Update — Last 12 Hours (Pacific Time)
Executive Summary
Wall Street rebounded Monday as AI and tech stocks steadied after the Nasdaq posted its worst month since March 2025, with oil prices tumbling roughly 6% on hopes of U.S.-Iran diplomatic progress — providing an additional tailwind for equities. The single most important development: Marvell Technology agreed to acquire Lumentum in a $115 billion all-stock deal, the largest AI data-center infrastructure bet of the year, reshaping the optical networking landscape. Markets are also bracing for a packed week of mega-cap earnings (Apple reports tonight) and Tuesday's U.S. midterm elections.
Sentiment Breakdown
| Sentiment | Count | Percentage |
|---|---|---|
| 🟢 Bullish | 118 | 51% |
| 🟡 Neutral | 52 | 23% |
| 🔴 Bearish | 60 | 26% |
Net Sentiment: Cautiously Bullish — A broad market bounce and deal activity dominate, but AI valuation anxiety, the Binance hack fallout, energy sector weakness, and midterm uncertainty keep bulls from running freely.
Top Market-Moving Headlines
🟢 M&A / AI Infrastructure | Marvell agrees $115 billion all-stock deal to buy Lumentum
Market Impact: The largest AI data-center deal of the cycle signals aggressive vertical integration in optical networking. Coherent surged 6.7% and Ciena rose 4% as the market repriced the entire optical sector.
🔴 Crypto | Binance clients pull $4.7 billion after $6.3 billion hack
Market Impact: The biggest heist in crypto history triggered massive outflows from the world's largest exchange; Morgan Stanley simultaneously slashed Coinbase to Underweight, cutting its target from $258 to $120.
🟢 AI / IPO | Anthropic posts $1.7B third-quarter revenue, plans $3.5 billion Japan IPO tranche
Market Impact: Anthropic's sharply narrowed losses and revenue acceleration ahead of its blockbuster IPO are a direct test of whether the AI trade can sustain premium valuations at scale.
🟢 Big Tech / Earnings | Apple reports after the close today; new CEO Ternus faces first earnings test
Market Impact: Apple trades at $338–$344 range heading into results; Oppenheimer warns valuation leaves little room for disappointment, making guidance — not the beat — the key variable.
🟢 Capital Markets | Oracle taps investors for $20 billion to finance AI expansion; Meta eyes $20 billion bond offering
Market Impact: Two of the largest capital raises of the year in a single session underscore the scale of AI infrastructure spending — and the debt markets' appetite to fund it.
🟢 Macro / Markets | Wall Street rebounds; Nasdaq posts worst month since March 2025 on AI rout
Market Impact: The bounce follows a bruising October sell-off driven by AI earnings disappointments; Morgan Stanley strategists say the correction is in its "final innings."
🟢 Hotels / Earnings | Marriott lifts annual room revenue growth forecast; stock surges 3.9%
Market Impact: Marriott's Q3 adjusted EPS of $3.02 beat the $2.83 estimate, and the raised full-year forecast signals resilient travel demand heading into year-end.
🔴 Semiconductors | Intel stock slides 5.7% to $62.01
Market Impact: Fallout from last week's earnings continues to weigh on Intel, extending the post-report sell-off with no near-term catalyst visible.
🔴 Biotech | Bright Minds Biosciences collapses 57.6% after FDA halts epilepsy trial
Market Impact: An FDA clinical hold on the company's lead epilepsy program is a near-total wipeout event; shares hit $23.31 in morning trading.
🟢 Pharma / Biotech | Inovio Pharmaceuticals surges 225% after FDA approval
Market Impact: A rare triple-digit biotech move driven by an FDA decision; limited broader market read-through but a significant single-stock event.
🟢 EV / Autos | Tesla registrations rise sharply across Europe in October, including +186% in Portugal
Market Impact: Strong European registration data — with gains in Sweden, Norway, Denmark, and Portugal — counters the narrative of slowing EV demand, even as Chinese rivals gain ground.
🟡 Midterm Elections | US midterm elections tomorrow; sectors bracing for pivot
Market Impact: Citi sees U.S. equity gains if Republicans retain Senate control; JPMorgan flags elevated post-midterm geopolitical risk but views any selloff as a buying opportunity.
🟢 AI / Advertising | OpenAI taps PubMatic and Magnite for ChatGPT ads; stocks climb 2.5% and 4%
Market Impact: Reports that OpenAI quietly struck programmatic ad agreements with both platforms is a meaningful revenue catalyst for the ad-tech sector.
🔴 Cybersecurity / Europe | Cyberattack hits supermarket refrigeration systems across Europe
Market Impact: Ahold Delhaize and Colruyt confirmed IT incidents affecting cooling infrastructure; the attack follows incidents at U.S. military bases, raising critical infrastructure concerns.
🟢 Pharma | Regeneron hits new 52-week high of $972.06, up 4.0%
Market Impact: Regeneron's move to a fresh 52-week high reflects continued strength in the large-cap biotech space amid broader market volatility.
🔴 Energy | Oil tumbles ~6% on U.S.-Iran talks; S&P 500 energy index falls 2.1%
Market Impact: Canadian Natural Resources fell 3.3%, ExxonMobil dropped 2.2%, and Cardinal Energy slid 4.3% — the oil price drop is a sector-wide headwind but a tailwind for the broader market.
🟢 Autos / M&A | SpaceX in talks to buy Boost Mobile or use EchoStar's network
Market Impact: EchoStar shares rose on the Washington Post report; a SpaceX wireless entry would be a major competitive disruption to the U.S. telecom sector.
🔴 Cybersecurity / Earnings | Check Point Software slides 4.6%–9.9% after Q3 2026 results disappoint
Market Impact: The miss adds to a pattern of the market punishing any tech earnings shortfall; Deutsche Bank simultaneously upgraded CrowdStrike to Buy, flagging an AI-driven cyber demand "tsunami."
🟢 Luxury / Earnings | Estee Lauder beats on both lines; raises annual forecast on luxury fragrance demand
Market Impact: The beat and raised guidance — driven by a shift away from promotions toward brand investment — is a positive signal for the prestige beauty sector heading into the holiday season.
🟡 AI / Macro | Anthropic IPO filing tests sustainability of AI trade; Deutsche Bank reverses US tech downgrade
Market Impact: Deutsche Bank's reversal — saying the selloff "has gone too far" — combined with Anthropic's IPO filing creates a pivotal moment for AI investor sentiment heading into the week.
Tickers in Focus
| Ticker | Price / Change | Context |
|---|---|---|
| MRVL | +3.5% (premarket) | Agreed to acquire Lumentum in $115B all-stock deal |
| LITE | — | Acquired by Marvell; optical networking consolidation |
| AAPL | $338–$344 range | Reports earnings after close today; new CEO Ternus's first call |
| INTC | $62.01 / -5.7% | Post-earnings fallout continues |
| NVDA | $207.69 / +1.5% | Bouncing with broader semiconductor recovery |
| GOOGL | $285.94 / +2.2% | Rebounding alongside tech sector |
| AMZN | +4.2% | Upgraded to Buy by Phillip Securities |
| BABA | $103.58 / +5.7% | Apple reportedly partnered with Alibaba for China AI features |
| MAR | +3.9% | Q3 EPS $3.02 vs $2.83 est.; raised full-year forecast |
| DRUG | $23.31 / -57.6% | FDA halted epilepsy trial; near-total wipeout |
| RGEN | $972.06 / +4.0% | New 52-week high |
| CRWD | +3.4% | Deutsche Bank upgraded to Buy; AI cyber demand thesis |
| CHKP | -4.6% to -9.9% | Q3 2026 results disappointed |
| PUBM | +2.5% | OpenAI ad platform agreements reported |
| MGNI | +4.0% | OpenAI ad platform agreements reported |
| ORCL | $130.06 / -0.5% | Plans $20B bond and share sale for AI expansion |
| META | — | Eyes $20B+ cross-border bond offering |
| RIVN | $12.55 / +3.2% | UBS upgraded to Buy from Neutral |
| ANT | — | Anthropic IPO; $1.7B Q3 revenue; $3.5B Japan tranche |
| TSLA | — | European registrations rise sharply; +186% in Portugal |
| FLNC | +4.2% (intraday) | CEO and CFO replaced; volatile session |
| EL | +2.5% | Beat on both lines; raised annual forecast |
| FOXA | — | Beat on both lines in fiscal Q1 2027 |
| TSEM | — | Q3 revenue $526.16M vs $522.08M estimate |
| GEO | +1.9%–4.0% | Won $200M 10-year ICE contract in Texas |
| OFRM | -10%–12.6% | Nationwide product recall weighing on shares |
| IOVA | $1.96 / +225.4% | FDA approval triggered massive surge |
| QURE | — | FDA accepted Huntington's therapy filing; initial +6.3% reversed |
| TEVA | $41.76 / -0.8% to -3% | Drug trial discontinuation |
| SPCE / SpaceX | +4.2% | Boost Mobile talks; Washington Post report |
| NARA | $10.80 | Narragansett Bancorp IPO debut on Nasdaq |
| FELE | +5.5% | D.A. Davidson upgraded to Buy; data center/mining thesis |
| RTSN | +10.2% | Guggenheim initiated coverage with bullish outlook |
Market Implications
The October AI rout has created a bifurcated setup heading into November. Morgan Stanley's "final innings" call on the correction, Deutsche Bank's reversal on U.S. tech, and the broad Monday bounce suggest institutional buyers are stepping in selectively — but the market remains unforgiving of any earnings miss, as Intel and Check Point demonstrated. Apple's report tonight is the week's defining moment: at current valuations, guidance quality matters far more than whether the company beats the quarter.
The Marvell-Lumentum $115 billion deal is the most consequential structural development of the session. It signals that AI data-center infrastructure spending is accelerating into vertical integration — chip designers are now buying their own optical supply chains. This has direct read-throughs for Coherent, Ciena, and the broader optical networking space, and raises the competitive stakes for any company still operating as a standalone component supplier.
The 6% oil price drop — driven by U.S.-Iran diplomatic hopes — is a double-edged macro signal. It relieves inflation pressure and boosts consumer discretionary and transport stocks, but hammers energy names across North America and Europe. With the midterms tomorrow and payrolls data later this week, the market faces a compressed calendar of catalysts that could quickly reverse Monday's relief rally if any of them disappoint.
Key Takeaways
- 🟢 MRVL/LITE — $115B all-stock deal reshapes AI optical networking; Coherent and Ciena are the clearest read-through beneficiaries
- 🔴 Binance — $4.7B in client outflows after the $6.3B hack; crypto infrastructure trust is under serious pressure
- 🟢 ANT (Anthropic) — $1.7B Q3 revenue and narrowing losses ahead of IPO; the AI trade's sustainability is now being priced in real time
- 🟢 AAPL — Tonight's earnings call is new CEO Ternus's first test; guidance on China and memory costs matters more than the headline beat
- 🟢 ORCL + META — Combined $40B+ in planned capital raises in a single session; AI infrastructure spending shows no signs of slowing
- 🟢 MAR — Q3 EPS beat and raised full-year forecast confirm resilient travel demand; hospitality sector holding up well
- 🔴 INTC — Shares at $62.01, down 5.7%; post-earnings fallout continues with no near-term recovery catalyst
- 🔴 DRUG (Bright Minds) — FDA clinical hold on epilepsy trial caused a 57.6% collapse; binary biotech risk is very real
- 🟢 IOVA (Inovio) — +225.4% on FDA approval; a reminder that regulatory catalysts can be transformative overnight
- 🔴 CHKP — Q3 miss triggered a near-10% drop; cybersecurity is not immune to earnings punishment even in a strong demand environment
- 🟢 CRWD — Deutsche Bank upgrade to Buy on AI-driven cyber demand "tsunami"; positioned as a beneficiary of the same AI wave hurting others
- 🟢 TSLA — European registrations up sharply including +186% in Portugal; European demand recovery is real despite Chinese competition
- 🔴 Energy sector — Oil -6% on Iran talks; ExxonMobil -2.2%, Canadian Natural Resources -3.3%; sector rotation away from energy is accelerating
- 🟢 PUBM + MGNI — OpenAI ad platform deals are a structural positive for programmatic ad-tech; watch for follow-on volume
- 🟡 Midterms — Citi sees equity upside if Republicans hold Senate; JPMorgan flags post-election geopolitical risk as a potential buying opportunity
- 🟡 Payrolls — Citi forecasts only 65,000 jobs added in October; a soft number could shift Fed rate expectations and market tone by Friday
- 🔴 Alstom — Stock plunged 27.4% on shock preliminary results; a stark reminder of European industrial earnings risk
- 🟢 EL (Estee Lauder) — Beat and raised guidance on luxury fragrance strength; prestige beauty is a bright spot in consumer spending
- 🟢 RIVN — UBS upgraded to Buy; the EV sector is seeing selective analyst re-engagement after the October selloff
- 🔴 Cyberattack on European supermarket fridges — Ahold Delhaize and Colruyt affected; critical infrastructure cyber risk is expanding beyond financial and tech targets
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/